Bone Involvement in Hodgkin’s Lymphoma: Clinical Features and Outcome
Author(s) -
Francesco Gaudio,
Pasquale Pedote,
Artor Niccoli Asabella,
Giuseppe Ingravallo,
Paola Del Sindaco,
Vito Alberotanza,
Tommasina Perrone,
F.E. Laddaga,
Giuseppe Rubini,
Amato Antonio Stabile Ianora,
Giorgina Specchia
Publication year - 2018
Publication title -
acta haematologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.574
H-Index - 56
eISSN - 1421-9662
pISSN - 0001-5792
DOI - 10.1159/000490489
Subject(s) - medicine , osteosclerosis , osteolysis , nodular sclerosis , lymphoma , disease , retrospective cohort study , surgery , radiology , hodgkin lymphoma
Hodgkin's lymphoma (HL) is now a highly curable disease, with an improving 5-year survival rate that has now reached 86%. At the time of presentation, HL is usually almost entirely confined to the lymph nodes. We performed a retrospective single-institution study of 384 cases with a median follow-up of 44 months, with the aim of identifying clinical and radiological characteristics and outcomes of patients with bone HL; 32 patients (8%) had primary bone involvement, always with concurrent nodal disease. These included 22 men (69%) and 10 women (31%) with the median age as 41 years. Advanced stages and nodular sclerosis histology prevailed among the subgroup. Radiographic features of bone HL are not specific but indicate a destructive malignant process with osteosclerosis and/or osteolysis. With current chemotherapeutic regimens, the long-term prognosis of patients with osseous HL appears good. The presence of bone lesions in HL should not be interpreted as implying a worse prognosis than without bone involvement.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom